Amazon’s Trainium Chips Sell Out as AWS Pledges $200B Capex; GLP-1 Program Launches
Amazon’s custom Trainium AI chips deliver 30% better cost-performance than GPU-based training and have sold out next-generation units, boosting AWS’s profitability under a $200 billion capex plan. Amazon One Medical’s weight-management program adds GLP-1 treatments with virtual and in-person care, pharmacy services and fast delivery to tap into the near-$100 billion market.
1. Trainium AI Chips Boost AWS Margins
Amazon has developed its Trainium custom AI training chips to reduce reliance on GPU providers, offering 30% better cost-performance compared with GPU-based solutions. Next-generation Trainium units are fully sold out, reflecting strong enterprise demand and reinforcing AWS’s margin expansion strategy as part of its $200 billion infrastructure investment.
2. One Medical GLP-1 Program Launch
Amazon One Medical has introduced a weight-management program integrating GLP-1 treatments with virtual and in-person care, pharmacy fulfillment and expedited delivery. The service enters the near-$100 billion GLP-1 market, leveraging Amazon’s healthcare ecosystem, though it remains a smaller growth driver relative to AWS’s cloud and AI businesses.